SCHEMBL18626447

SCHEMBL18626447

O=C(N[C@H](Cc1ccc(-c2ccccc2)cc1)C[C@@H](CCOCCCO)C(=O)O)c1c[nH]nn1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 19/20 0.55
▸ ACE P12821 4/20 0.47
▸ MMEL1 Q495T6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930478 0.93 MME (0.62) MMEACEMMEL1
SCHEMBL20306265 0.89 MME (0.52) MMEMMEL1
SCHEMBL20306264 0.88 MME (0.54) MMEACEMMEL1
SCHEMBL16930646 0.87 MME (0.61) MMEACEMMEL1
SCHEMBL18626456 0.86 MME (0.53) MMEACEMMEL1
SCHEMBL16940998 0.85 MME (0.76) MMEMMEL1
SCHEMBL16930500 0.84 MME (0.54) MMEMMEL1
SCHEMBL16930533 0.84 MME (0.54) MMEACEMMEL1
SCHEMBL16930647 0.83 MME (0.55) MMEMMEL1
SCHEMBL20099619 0.82 MME (0.48) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593110-B2 Neprilysin inhibitors Theravence Biopharma R&D IP, LLC (US) 2017-03-14 — — US disclosed
Send feedback